Table 2.
Clinical characteristics and inflammation biomarkers in the training cohort. Data are shown as the mean ± SD or median (P25 and P75).
| Variable | Training cohort | ||
|---|---|---|---|
| Sepsis (-), n = 467 | Sepsis (+), n = 55 | ||
| Age | 55.41 ± 13.05 | 59.29 ± 11.24 | 0.02∗ |
| Sex | |||
| Male | 305 | 34 | 0.61 |
| Female | 162 | 21 | |
| Perioperative blood transfusion | |||
| Yes | 165 | 38 | ≤0.001∗ |
| No | 302 | 17 | |
| ASA scores | |||
| 1 | 10 | 1 | ≤0.001∗ |
| 2 | 392 | 42 | |
| 3 | 64 | 11 | |
| 4 | 1 | 1 | |
| Diabetes | |||
| Yes | 78 | 17 | 0.01∗ |
| No | 389 | 38 | |
| BMI | 23.5 ± 3.21 | 24.69 ± 3.12 | 0.01∗ |
| Operative time (min) | 280 (210-340) | 345 (262.5-431) | 0.03∗ |
| Intraoperative blood loss | 300 (200-600) | 400 (200-800) | |
| Preoperative ALT | 44 (20.45-122.5) | 62 (24.5-104.9) | 0.53 |
| Preoperative AST | 35.6 (20.85-98.95) | 42.6 (26.4-81.9) | 0.47 |
| Preoperative direct bilirubin | 5.1 (3.2-31) | 35.5 (5.1-132.05) | ≤0.001∗ |
| Inflammation biomarkers | |||
| IL-1 (pg/ml) | 5 (5-5) | 5 (5-5) | 0.46 |
| IL-2 (U/ml) | 767 (600-1023) | 1034 (699.5-1378.5) | ≤0.001∗ |
| IL-6 (pg/ml) | 82.2 (46.15-164.5) | 171 (102-274) | ≤0.001∗ |
| IL-8 (pg/ml) | 89 (40.2-190) | 105 (55.55-242) | 0.18 |
| IL-10 (pg/ml) | 5.78 (5-10) | 9.56 (5.86-14.35) | ≤0.001∗ |
| TNF-α (pg/ml) | 16.3 (11-30.55) | 16.5 (10.5-24.95) | 0.50 |
| PCT (ng/ml) | 0.55 (0.28-1.01) | 1.53 (0.809-3.29) | ≤0.001∗ |
| CRP (mg/dl) | 3.73 (1.96-6.29) | 6.62 (4.62-9.35) | ≤0.001∗ |
| NLR | 11.1 (7.73-15.73) | 12.17 (8.10-16.94) | 0.39 |